Immune responses of anti-HAV in children vaccinated with live attenuated and inactivated hepatitis A vaccines (Q43982810)

28 November 2017

Immune responses of anti-HAV in children vaccinated with live attenuated and inactivated hepatitis A vaccines (English)

1 reference

28 November 2017

1 reference

1 reference

2

Zhiyi Xu

1 reference

28 November 2017

Xuan-Yi Wang

1

1 reference

28 November 2017

Xing Yao

3

1 reference

28 November 2017

Meiying Tian

4

1 reference

28 November 2017

Liangdi Zhou

5

1 reference

28 November 2017

Lifang He

6

1 reference

28 November 2017

Yumei Wen

7

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

28 November 2017

1 reference

28 November 2017

22

1 reference

28 November 2017

15-16

1 reference

28 November 2017

1941-1945

1 reference

Primary study of attenuated live hepatitis A vaccine (H2 strain) in humans

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.007

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.007

Field efficacy trial of inactivated hepatitis A vaccine among children in Thailand (an extended abstract)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.007

Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.007

Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.007

Functional diversity of helper T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.007

Dietary ribonucleotides modulate type 1 and type 2 T-helper cell responses against ovalbumin in young BALB/cJ mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.007

Quantitative analysis of specific Th1/Th2 helper cell responses and IgG subtype antibodies in interferon-alpha-treated patients with chronic hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.007

Production, quality control and characterization of an inactivated hepatitis A vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.007

Method for quantitation of IgG subclass antibodies in mouse serum by enzyme-linked immunosorbent assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.007

Time course of hepatitis A antibody production after active, passive and active/passive immunisation: the results are highly dependent on the antibody test system used

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.007

Properties of IgG subclasses to human cytomegalovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.007

Epitope-specific distribution of IgG subclasses against antigenic domains on glycoproteins of human cytomegalovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.007

10.1016/J.VACCINE.2003.11.007

7 January 2021

Identifiers

DOI

1 reference

28 November 2017

1 reference